Calgary, Canada
TESER Technologies Inc, founded in 2020, is a biomedical tech startup headquartered in Canada, strategically positioned at the intersection of the Biotechnology, Health Care, and Manufacturing industries. The company pioneers in providing UV-C sanitization solutions that promise 99.99% effectiveness, emphasizing their commitment to innovation and public health.
Their flagship product, the TESER ACT unit, leverages ULTRASAN technology for rapid sanitization of high-touch objects and devices, effectively tackling pathogens such as COVID-19, Vaccinia virus, E.coli, MS2, and Staph in under a minute. Currently undergoing testing at prominent institutions like the University of Alberta and McGill University, they are actively pursuing Health Canada certifications.
Potential investors should note the absence of a last investment round, suggesting a unique opportunity for venture capital to pioneer and steer a groundbreaking technology poised to revolutionize sanitization standards in a post-pandemic world.
